Tdp 43

Latest News for: tdp 43

Edit

AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial ...

Nasdaq Globe Newswire 19 Mar 2026

AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial of PET tracer ACI-19626, at AD/PDTM 2026 ... .

Edit

Seeing ALS Through the Eye: Amydis Receives Phase 2 NIH Grant Award to Advance a Novel Approach to Detect Biomarker TDP-43

PR Newswire 11 Mar 2026

... 43 (TDP-43) associated with neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and Limbic-predominant Age-related TDP-43 Encephalopathy (LATE).

Edit

Ubiquitin-specific peptidase-19 links TDP-43 aggregation to ER stress

PNAS 10 Mar 2026

... of TDP-43, a process dependent on the ubiquitin-proteasome system.

Edit

Neuronal TDP-43 regulates myelin formation via neurexin 1 mRNA stabilization

PNAS 25 Feb 2026

SignificanceTAR DNA-binding protein 43 (TDP-43) is a major component ...

Edit

MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease

Rutland Herald 14 Jan 2026

VICTORIA, British Columbia--(BUSINESS WIRE)--Jan 14, 2026-- ....

Edit

MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease (Form 6-K) (MindWalk Holdings Corp)

Public Technologies 14 Jan 2026

MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease ... Intrabodies Selective for Pathogenic TDP-43, is available on bioRxiv (DOI.

Edit

Dewpoint Therapeutics Announces TDP-43 Condensate Modulator Development Candidate for Treatment of ALS and Related Neurodegenerative Diseases

Nasdaq Globe Newswire 08 Jan 2026

First-in-class condensate-modulating small molecule Development Candidate targeting pathogenic TDP-43 condensates in ALS, FTD and traumatic brain injury ... .

Edit

Dewpoint Therapeutics Announces TDP-43 Condensate Modulator Development Candidate for Treatment

Hastings Tribune 08 Jan 2026

... across TDP-43 proteinopathies including Traumatic Brain Injury and .

Article Search

tools

You can search using any combination of the items listed below.

Language:

Sort:

Indexed:

Search:

Duplicates:

Podcasts:

Latest News for: tdp 43

AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial ...

Seeing ALS Through the Eye: Amydis Receives Phase 2 NIH Grant Award to Advance a Novel Approach to Detect Biomarker TDP-43

Ubiquitin-specific peptidase-19 links TDP-43 aggregation to ER stress

Neuronal TDP-43 regulates myelin formation via neurexin 1 mRNA stabilization

MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease

MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease (Form 6-K) (MindWalk Holdings Corp)

Dewpoint Therapeutics Announces TDP-43 Condensate Modulator Development Candidate for Treatment of ALS and Related Neurodegenerative Diseases

Dewpoint Therapeutics Announces TDP-43 Condensate Modulator Development Candidate for Treatment

Article Search

EXPLORE WN.com